SNCA and Alzheimer disease: While it is possible to perform controlled aggregation reactions of proteins in the test-tube, such as the aggregation of alpha-synuclein (αS) associated with Parkinson's disease and amyloid-β (Aβ) and tau associated with Alzheimer's disease (AD), extrapolation of this data to what happens during the course of disease is challenging.